Navigation Links
SMS Sample Management System

ProductsSMS Sample Management System
Company Siemens Medical Solutions Diagnostics
Item SMS Sample Management System
Features 
  • Provides no-pause sample loading for continuous feeding to the IMMULITE 2000 / IMMULITE 2500
  • A robotic arm that can rotate 340 in the horizontal plane with a wrist that can pivot a full 360 in the same plane, providing flexible sample positioning within the smallest possible physical area
  • Total sample capacity of 200 samples (four drawers of 50 samples each)
  • Universal design provides the capability to link with track-based systems
  • Increases usable walk-away time
  • Requires no additional LIS interface
  • Reduces labor-intensive steps of the pre- and postanalytical phases of daily workflow
  • Provides immediate access to samples
  • Accepts clinical chemistry system racks
Description The SMS is a robotic sample feeder that interfaces with the IMMULITE 2000 and IMMULITE 2500 systems via a robotic arm and the SMS software. Continuous sample loading, onboard sample capacity of 200 tubes and compatibility with clinical chemistry system racks are just some of the features that make the SMS a practical and affordable solution for improving productivity. The SMS and the IMMULITE 2000 / IMMULITE 2500 systems operate as a single, integrated platformyet the IMMULITE 2000 and IMMULITE 2500 systems are completely independent of the SMS, giving customers the flexibility they need when using automated sample processors. The SMS can also be used to form the most powerful immunoassay system availablethe Immunoassay Workcellwhich links two IMMULITE 2000 and/or IMMULITE 2500 systems together and facilitates operator interfacing from a single sample-entry point.
Info Siemens Medical Solutions Diagnostics
Customer Service: 800-255-3232 or 914-631-8000
Web site: http://www.siemens.com/diagnostics-products

Related medicine products :

1. m1000 Automated Sample Preparation
2. StatSampler
3. Vidiera NsP Nucleic Acid Sample Preparation Platform
4. Vidiera NsD Nucleic Acid Sample Detection Platform
5. FISKE® 210 Micro-Sample Osmometer
6. The Advanced® 2020 Multi-Sample Osmometer
7. The Advanced® 3250 Single-Sample Osmometer
8. The Advanced Model 3900 Multi-Sample Osmometer
9. VACUETTE Paediatric Multi-Sample Needle
10. Protein G Samples Pack - .13 OD ; .25 OD; .50 OD per sq. cm
11. Protein A Sample Pack - .13 OD ; .25 OD; .50 OD per sq. cm
Eppendorf sealing mat, 96 well
Chemically Resistant Sealing Mat for 384-well Plate
96-well Silicone Compression
Sealing Mat for 384-well PCR plate
Medicine Products:
(Date:12/2/2009)... , GRAND RAPIDS, Mich., Dec. 3 ...ave determined precisely how the plant hormone abs...elp plants respond to environmental stresses such ... the journal Nature , could help engineer crops t...and combat global food shortages. The findings co...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repor...eport is available in its catalogue: ,, Steri...tp://www.reportlinker.com/p0166820/Sterilization-T...North American sales of capital equipment to the s...arket,s compound annual growth rate for 2009-2014....
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repo...report is available in its catalogue: ,, Kina....reportlinker.com/p0166819/Kinase-Inhibitors-Globa...arket, providing data for the years 2005 through 2...nnual growth rates (CAGRs) through 2014 ,, An ...
(Date:12/2/2009)... , WASHINGTON, Dec. 2 /PRNewswire-USNewswire/...oday on " Supplement Safety Now ," an initiati...her organizations, the Council for Responsible Nut...enting the dietary supplement industry, issued the... Mister , President and CEO: ,, "We share th...
(Date:12/2/2009)... , SEOUL, South Korea, Dec. 2 /PRNewswire-...est of Seoul, Korea Telecom (KT), MacroEye and Qua...ireless Reach(TM) initiative, today announced the ...s, services and applications through the "Seoul Fa...e handsets and devices to caregivers and senior ci...
Breaking Medicine News(10 mins):Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 3Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 3Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 5Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 6Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 7Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 8Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 9Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 10Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 11Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 12Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4
...h shows the chickenpox vaccine loses some of its e.../ Parents are encouraged to vaccinate their childr...ths. Consequently, researchers were prompted to fu...13 months or older who had been afflicted with the...
...th Organization estimates that 40 million people a...hem in developing countries. In some African count... Last year, an estimated 700,000 children caught H...o keep them from passing the virus to their newbor...
...is a chronic but deadly condition caused by the he... enlarges as it becomes weaker and weaker. An es...ich will kill half of them within five years. It c... who took statins ( work by reducing inflammation,...
...survivors can now get up and get moving. Breast ca...r women, reported higher body esteem and better mo... study. Researchers compared 40 women who said...tudes toward their physical condition and sexual a...
... the most antibiotics , or who took the drugs for ...eveloping breast cancer over an average of about 1...ugs, the study showed. Also, since antibiotics ... who never took the drugs were unusually healthy a...
...h shows chronic cough affects women more severely .... // Researchers from the University of Massac...en and 56 men seeking medical attention for chroni...tly more women than men in the chronic cough group...
Other Medicine News:Health News:Drug to stop HIV spread to babies may Indirectly harm The Mother 2
(Date:12/2/2009)...c. 2 Cephalon, Inc. (Nas...awsuit in U.S. District Court in Delaware against ... U.S. Patent Nos. 7,132,570 (the ",570 Patent"), 7...16 Patent") for the Cephalon product NUVIGIL®...ee-year period of marketing exclusivity for NUVIGI...
(Date:12/2/2009).... 2 Reportlinker.com announces tha... catalogue: ,, Pharmaceutical Contract Manufa...w.reportlinker.com/p0164248/Pharmaceutical-Contrac..., Global pharma industry faces numerous challenge... markets, rising cost of new product development, ...
(Date:12/2/2009)...c. 2 Jupiter Medical Ce...iagnostic tools available into its imaging program...care. The system delivers highly detailed images o...lution and unique applications, including dual bre... patients with renal dysfunction. This results in...
Breaking Medicine Technology:Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2US Oncology Reports Second Quarter Operating Results 53858 1US Oncology Reports Second Quarter Operating Results 53858 2US Oncology Reports Second Quarter Operating Results 53858 3US Oncology Reports Second Quarter Operating Results 53858 4US Oncology Reports Second Quarter Operating Results 53858 5US Oncology Reports Second Quarter Operating Results 53858 6US Oncology Reports Second Quarter Operating Results 53858 7US Oncology Reports Second Quarter Operating Results 53858 8US Oncology Reports Second Quarter Operating Results 53858 9US Oncology Reports Second Quarter Operating Results 53858 10US Oncology Reports Second Quarter Operating Results 53858 11US Oncology Reports Second Quarter Operating Results 53858 12US Oncology Reports Second Quarter Operating Results 53858 13US Oncology Reports Second Quarter Operating Results 53858 14US Oncology Reports Second Quarter Operating Results 53858 15US Oncology Reports Second Quarter Operating Results 53858 16US Oncology Reports Second Quarter Operating Results 53858 17US Oncology Reports Second Quarter Operating Results 53858 18US Oncology Reports Second Quarter Operating Results 53858 19US Oncology Reports Second Quarter Operating Results 53858 20US Oncology Reports Second Quarter Operating Results 53858 21US Oncology Reports Second Quarter Operating Results 53858 22US Oncology Reports Second Quarter Operating Results 53858 23US Oncology Reports Second Quarter Operating Results 53858 24US Oncology Reports Second Quarter Operating Results 53858 25Efforts by Blue Cross Blue Shield of Michigan Physician Practices Help Michigan Become a Leading Adopter of E prescribing 53856 1Efforts by Blue Cross Blue Shield of Michigan Physician Practices Help Michigan Become a Leading Adopter of E prescribing 53856 2Efforts by Blue Cross Blue Shield of Michigan Physician Practices Help Michigan Become a Leading Adopter of E prescribing 53856 3BD Adds Surveillance Capability to Infectious Disease Portfolio 53851 1BD Adds Surveillance Capability to Infectious Disease Portfolio 53851 2BD Adds Surveillance Capability to Infectious Disease Portfolio 53851 3